Immunebro Therapeutics Inc.
Chicago, IL
- UEI
- VS89GSB9NDA7
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1346 W Fillmore St b, Chicago, IL 60607, USA
- Website
- immunebro.com
- Founded
- 2019
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Engager t cell: a simple solution for off-the-shelf t cell therapy for cancer - project summary autologous chimeric… | National Cancer Institute | $361,635 |
Quick answers
What is Immunebro Therapeutics Inc.'s UEI?
Immunebro Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is VS89GSB9NDA7.
Where is Immunebro Therapeutics Inc. located?
Immunebro Therapeutics Inc.'s physical address in SAM.gov is 1346 W Fillmore St b, Chicago, IL 60607, USA.
Is Immunebro Therapeutics Inc. registered in SAM.gov?
Yes. Immunebro Therapeutics Inc.'s SAM.gov registration is active through May 11, 2027.
What is Immunebro Therapeutics Inc.'s most recent federal award?
Immunebro Therapeutics Inc.'s most recent federal grant award is Engager t cell: a simple solution for off-the-shelf t cell therapy for cancer - project summary autologous chimeric… (R43CA281523), from National Cancer Institute, on May 1, 2024.
On GovTribe
See Immunebro Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors